Skip to content

Takeda Pharmaceutical Co Ltd

TAK NYSE SEC CIK 1395064

Follow Takeda Pharmaceutical Weekly email: filings, results, news

News

1 story filed under Takeda Pharmaceutical

Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?

Markets 41 d ago also on KROS

Profile

Headquarters: TOKYO
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 1 story clustered from the RSS aggregator